Rodney F Minchin Selected Research

Arylamine N-Acetyltransferase

12/2020	Effect arylamine N-acetyltransferase 1 on morphology, adhesion, migration, and invasion of MDA-MB-231 cells: role of matrix metalloproteinases and integrin αV.
4/2015	Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines.
2/2010	Small molecule inhibition of arylamine N-acetyltransferase Type I inhibits proliferation and invasiveness of MDA-MB-231 breast cancer cells.
1/2007	Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rodney F Minchin Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 05/2004
4	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2010
3	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2013 - 09/2010
3	Schizophrenia (Dementia Praecox) 09/2010 - 01/2008
2	Prostatic Neoplasms (Prostate Cancer) 02/2011 - 01/2007
2	Spinal Dysraphism (Spina Bifida) 01/2011 - 01/2007
1	Kaposi Sarcoma (Kaposi's Sarcoma) 10/2021
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Lymphatic Metastasis 01/2019
1	Starvation 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Connective Tissue Diseases (Connective Tissue Disease) 06/2015
1	Triple Negative Breast Neoplasms 04/2015
1	Inflammation (Inflammations) 01/2011
1	Adenocarcinoma 02/2010
1	Melanoma (Melanoma, Malignant) 01/2006
1	Glucocorticoid Receptor Deficiency 01/2003

Drug/Important Bio-Agent (IBA)

12	N-acetyltransferase 1IBA 01/2022 - 05/2004
10	EnzymesIBA 01/2022 - 01/2007
9	Pharmaceutical PreparationsIBA 01/2022 - 01/2006
4	Arylamine N-AcetyltransferaseIBA 12/2020 - 01/2007
3	Proteins (Proteins, Gene)FDA Link 11/2019 - 05/2010
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2012 - 01/2007
2	1-dodecylpyridoxal (PLD)IBA 10/2021 - 01/2021
2	liposomal doxorubicin (Doxil)FDA Link 10/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 11/2019 - 07/2018
2	Cadherins (E-Cadherin)IBA 01/2018 - 02/2011
2	Small Interfering RNA (siRNA)IBA 01/2018 - 04/2015
2	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2011 - 09/2010
2	CarcinogensIBA 02/2010 - 01/2007
1	Oxygen (Dioxygen)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	XenobioticsIBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 11/2019
1	Matrix Metalloproteinases (MMPs)IBA 11/2019
1	Hypoxia-Inducible Factor 1IBA 11/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Estrogen ReceptorsIBA 07/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Methionine (L-Methionine)FDA Link 02/2017
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 06/2015
1	Antinuclear AntibodiesIBA 06/2015
1	Dopamine (Intropin)FDA LinkGeneric 11/2013
1	monoamine-sulfating phenol sulfotransferaseIBA 11/2013
1	Environmental CarcinogensIBA 01/2012
1	Fibrinogen (Factor I)FDA Link 01/2011
1	Macrophage-1 Antigen (Macrophage 1 Antigen)IBA 01/2011
1	theasinensin AIBA 01/2011
1	Histone Deacetylase InhibitorsIBA 01/2011
1	trichostatin A (A 300)IBA 01/2011
1	(Z)- 5- (2'- hydroxybenzylidene)- 2- thioxothiazolidin- 4- oneIBA 02/2010
1	SulfotransferasesIBA 02/2009
1	5' Untranslated Regions (5' UTR)IBA 01/2008
1	AndrogensIBA 01/2007
1	PolyaminesIBA 01/2006
1	N(1),N(11)-diethylnorspermineIBA 01/2006
1	Hormones (Hormone)IBA 01/2003
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2003

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2021 - 01/2012
3	Therapeutics 01/2021 - 02/2011